T & I Global Ltd files Reg 29(2) disclosure for Counter Cyclical Investment Pvt Ltd

What T & I Global Ltd announced

On 20 July 2026, T & I Global Ltd (BSE: 522294) submitted a disclosure under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011. The filing relates to a proposed acquisition of shares in Counter Cyclical Investment Pvt Ltd. The exchange has recorded the receipt of this disclosure, signalling that the acquisition meets the threshold that triggers mandatory reporting under the SAST framework.

Details of the Reg 29(2) filing

Regulation 29(2) requires a target company to disclose any acquisition that results in a person or entity acquiring 25% or more of its voting rights, or any increase in shareholding that crosses that threshold. The filing by T & I Global Ltd confirms that its transaction with Counter Cyclical Investment Pvt Ltd has met this criterion. The document submitted to BSE does not provide quantitative specifics such as the exact share percentage acquired, the consideration paid, or the financing structure. It merely acknowledges the regulatory requirement and the parties involved.

Key facts at a glance

Why this matters for investors

The Reg 29(2) filing alerts shareholders that a substantial share acquisition is underway, which could affect control dynamics, voting power, and future strategic direction of the target entity. While the filing does not reveal the size of the stake or the price paid, the mere fact that the threshold has been crossed may lead to further regulatory scrutiny, mandatory open‑offer requirements, or the need for shareholder approvals under the SAST rules. Investors should monitor subsequent disclosures for details on the transaction structure, financing, and any conditions precedent that may impact the final outcome.

Conclusion

T & I Global Ltd’s Reg 29(2) disclosure on 20 July 2026 confirms a substantial acquisition of Counter Cyclical Investment Pvt Ltd, but the filing does not disclose the transaction’s financial terms or exact shareholding percentage. Further filings are expected to elaborate on the deal’s specifics and any regulatory approvals required before completion.